Remission of Refractory PASH Syndrome Using Ixekizumab and Doxycycline.

Remission of Refractory PASH Syndrome Using Ixekizumab and Doxycycline. J Drugs Dermatol. 2020 Nov 01;19(11):1123 Authors: Gul MI, Singam V, Hanson C, Neill BC, Aires DJ, Rajpara AN PMID: 33196740 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33196740?dopt=Abstract

Source: Journal of Drugs in Dermatology - November 19, 2020 Category: Dermatology Tags: J Drugs Dermatol Source Type: research

More News: Dermatology | Doxycycline | Skin